Scutellaria barbata D Don inhibits colorectal cancer growth via suppression of multiple signaling pathways

Integrative Cancer Therapies

Volumn 13, Issue 3, 2014, Pages 240-248

  Lin, Jiumao ^a   Chen, Youqin ^b   Cai, Qiaoyan ^a   Wei, Lihui ^a   Zhan, Youzhi ^a   Shen, Aling ^a   Sferra, Thomas J ^b   Peng, Jun ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

anticancer; apoptosis; colorectal cancer; proliferation; Scutellaria barbata D Don; signaling pathway

Indexed keywords

ALCOHOL; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; SCUTELLARIA BARBATA EXTRACT; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL PROLIFERATION; CHINA; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; HERB; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCUTELLARIA BARBATA; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; WEIGHT GAIN; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HT-29 CELL LINE; ISOLATION AND PURIFICATION; NUDE MOUSE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PLANT EXTRACTS; SIGNAL TRANSDUCTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84900808553     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735413508811     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 ; 61: 69-90
2. Gustin DM, Brenner DE. Chemoprevention of colon cancer: current status and future prospects. Cancer Metastasis Rev. 2002 ; 21: 323-348
3. Cai Q, Lin J, Wei L, et al. Hedyotis diffusa Willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway. Int J Mol Sci. 2012 ; 13: 6117-6128
4. Inghirami G, Chiarle R, Simmons WJ, Piva R, Schlessinger K, Levy DE. New and old functions of STAT3: a pivotal target for individualized treatment of cancer. Cell Cycle. 2005 ; 4: 1131-1133
5. Klampfer L. Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr Cancer Drug Targets. 2006 ; 6: 107-121
6. Darnell JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer. 2002 ; 2: 740-749
7. Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci. 2009 ; 1171: 59-76
8. Kusaba T, Nakayama T, Yamazumi K, et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep. 2006 ; 15: 1445-1451
9. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009 ; 15: 103-113
10. Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009 ; 15: 79-80
11. Xiong H, Zhang Z, Tian X, et al. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia. 2008 ; 10: 287-297
12. Sebolt-Leopold JS. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene. 2000 ; 19: 6594-6599
13. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995 ; 9: 726-735
14. Wang X, Wang Q, Hu W, Evers BM. Regulation of phorbol estermediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-κB- dependent pathway. Oncogene. 2004 ; 23: 1885-1895
15. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007 ; 26: 3291-3310
16. Gordaliza M. Natural products as leads to anticancer drugs. Clin Transl Oncol. 2007 ; 9: 767-776
17. Prakobwong S, Gupta SC, Kim JH, et al. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways. Carcinogenesis. 2011 ; 32: 1372-1380
18. Prasad S, Yadav VR, Sung B, et al. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res. 2012 ; 18: 4942-4953
19. Pharmacopoeia of the People's Republic of China. Beijing, China: Chinese Medical Science and Technology Press ; 2010: 109-110.
20. Wei L, Chen Y, Lin J, et al. Scutellaria barbata D. Don induces apoptosis of human colon carcinoma cell through activation of the mitochondrion-dependent pathway. J Med Plants Res. 2011 ; 5: 1962-1970
21. Wei L, Lin J, Xu W, Hong Z, Liu X, Peng J. Inhibition of tumor angiogenesis by Scutellaria barbata D. Don via suppressing proliferation, migration and tube formation of endothelial cells and downregulation of the expression of VEGF-A in cancer cells. J Med Plants Res. 2011 ; 5: 3260-3268
22. Wei L, Lin J, Xu W, et al. Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of Hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci. 2012 ; 13: 9419-9430
23. Wei LH, Lin JM, Wu GW, et al. Scutellaria barbata D. Don induces G1/S arrest via modulation of p53 and Akt pathways in human colon carcinoma cells. Oncol Rep. 2013 ; 29: 1623-1628
24. Li M, Zhang Y, Zhai Q, et al. Thymosin β-10 is aberrantly expressed in pancreatic cancer and induces JNK activation. Cancer Invest. 2009 ; 27: 251-256
25. Ji HF, Li XJ, Zhang HY. Natural products and drug discovery. EMBO Rep. 2009 ; 10: 194-200
26. Lee KH. Research and future trends in the pharmaceutical development of medicinal herbs from Chinese medicine. Public Health Nutr. 2000 ; 3: 515-522
27. Wang J. Treatment of food anaphylaxis with traditional Chinese herbal remedies: from mouse model to human clinical trials. Curr Opin Allergy Clin Immunol. 2013 ; 13: 386-391
28. Nurse P. Ordering S phase and M phase in the cell cycle. Cell. 1994 ; 79: 547-550
29. Morgan DO. Principles of CDK regulation. Nature. 1995 ; 374: 131-134
30. Kouraklis G, Theocharis S, Vamvakas P, et al. Cyclin D1 and Rb protein expression and their correlation with prognosis in patients with colon cancer. World J Surg Oncol. 2006 ; 4: 5
31. Domagala W, Welcker M, Chosia M, et al. p21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 years. Virchows Arch. 2001 ; 439: 132-140